Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)

NCT04637555 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped CLCZ696G2301E1 extension study did not start as the core study (CLCZ696G2301) did not meet the primary endpoint.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals